Hinge Health Inc. Class A Common Stock vs Nokia Corp — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Nokia Corp trades at $9.14 (market cap $54.54B). The key difference: Nokia Corp is far larger — about 6.4× Hinge Health Inc. Class A Common Stock's market cap, and Nokia Corp pays a 1.66% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Nokia Corp for 65 Days on average.
| HNGE | NOK | |
|---|---|---|
Market Cap | $8.48B | $54.54B |
Volume | 879,799 | 76,721,489 |
Sector | Health | Technology |
52-Week High | $105.14 | $16.83 |
52-Week Low | $31.17 | $5.55 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $8.10B | $52.57B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Nokia (NOK) trades at $9.40, down 5.05% in the last session, with a bearish technical signal. The company maintains a solid financial position with $19.89B in revenue and $651M net income for 2025, though profitability margins remain modest. Recent partnerships with Microsoft and ICEYE for AI and satellite communications highlight growth initiatives. Analyst consensus is bullish with a $17.50 price target, representing significant upside potential from current levels.
Nokia presents a compelling opportunity with strong analyst support and strategic positioning in 5G and AI infrastructure, though execution risks and competitive pressures persist. The stock's current valuation at 73x P/E appears stretched relative to 3.47% net margins, requiring careful monitoring of earnings growth to justify premium multiples. Near-term catalysts include Q3 2026 earnings and continued AI partnership developments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →